Attenuation of drug-stimulated topoisomerase II–DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIα

This publication has 26 references indexed in Scilit:

• Tumor Cell Resistance to Topoisomerase II Poisons: role for intracellular free calcium in the sensitization by inhibitors of calcium-calmodulin-dependent enzymes
  Biochemical Pharmacology, 1998
• Cell Cycle–coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities
  The Journal of cell biology, 1997
• Phosphorylation-independent Stimulation of DNA Topoisomerase IIα Activity
  Published by Elsevier ,1996
• Human Topoisomerase IIalpha is Phosphorylated in a Cell-Cycle Phase-Dependent Manner by a Proline-Directed Kinase
  European Journal of Biochemistry, 1995
• DNA Topoisomerases: Essential Enzymes and Lethal Targets
  Annual Review of Pharmacology and Toxicology, 1994
• Altered Phosphorylation, Biosynthesis and Degradation of the 170 kDa Isoform of Topoisomerase II in Amsacrine-Resistant Human Leukemia Cells
  Biochemical and Biophysical Research Communications, 1993
• Etoposide-induced DNA damage in human tumor cells: requirement for cellular activating factors
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
• HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II
  JNCI Journal of the National Cancer Institute, 1990
• Active involvement of Ca2+ in mitotic progression of Swiss 3T3 fibroblasts.
  The Journal of cell biology, 1990
• New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures
  Biochemistry, 1980